
Somnomed Ltd
ASX:SOM

Operating Margin
Somnomed Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
AU |
![]() |
Somnomed Ltd
ASX:SOM
|
92.9m AUD |
-2%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
216.2B USD |
17%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
165.1B USD |
28%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
134.9B USD |
18%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
131.7B USD |
22%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
106.7B USD |
19%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
59.5B USD |
14%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
48.4B EUR |
13%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
40.6B USD |
27%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
258.3B CNY |
36%
|
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
31.3B USD |
32%
|
Somnomed Ltd
Glance View
SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. SomnoMed has developed the SomnoDent, a collection of oral devices. SomnoDent includes two product line, such as signature line and standard line. Its signature line products include Herbst Advance Elite, Fusion, Flex and Classic, and standard line products include Herbst Advance, Air/Air+, Morning Repositioner and Alpha. SomnoMed has developed the SomnoBrux, a custom fit acrylic occlusal splint. SomnoBrux product includes Michigan. SomnoMed has developed the SomGauge, is an autoclavable instrument, which can be used to construct accurate and reliable bite records.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Somnomed Ltd's most recent financial statements, the company has Operating Margin of -2.4%.